Evidence map›Paper›PMID 42430392›Full record

ArticlePloS one2026

Adaptive geometric-attention network for two-stage lung nodule segmentation and malignancy classification in federated healthcare IoT edge environments.

Muhammad Sufyan, Jun Qian, Jianqiang Li, Azhar Imran, Fahad Sabah, Raheem Sarwar

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Muhammad SufyanCollege of Computer Science, Beijing University of Technology, Beijing, China.
Jun QianCollege of Computer Science, Beijing University of Technology, Beijing, China.
Jianqiang LiCollege of Computer Science, Beijing University of Technology, Beijing, China.
Azhar ImranCollege of Computer Science, Beijing University of Technology, Beijing, China.
Fahad SabahCollege of Computer Science, Beijing University of Technology, Beijing, China.
Raheem SarwarOTEHM, Manchester Metropolitan University, Manchester, United Kingdom.ORCID https://orcid.org/0000-0002-0640-807X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate segmentation and classification of lung nodules in computed tomography (CT) scans remains a critical challenge in early lung cancer detection within distributed healthcare Internet of Things (IoT) environments. This paper presents a novel two-stage framework called Adaptive Geometric-Attention Network (AGA-Net) that integrates geometric constraints with multi-scale attention mechanisms for precise nodule segmentation followed by uncertainty-aware malignancy classification in federated learning scenarios. Unlike existing approaches that rely on traditional convolutional architectures, our method introduces a Geometric-Constrained Attention Module (GCAM) that leverages the spherical nature of lung nodules and a Multi-Scale Uncertainty Quantification Network (MUQ-Net) for robust classification under privacy-preserving constraints. The proposed framework demonstrates superior performance across three benchmark datasets: LUNA16, LIDC-IDRI, and NSCLC-Radiomics, achieving a Dice coefficient of 0.927 for segmentation and AUC of 0.951 for malignancy classification while maintaining computational efficiency validated on IoT-class edge hardware including the NVIDIA Jetson AGX Orin and Jetson Orin Nano. The integration of geometric priors with attention mechanisms, uncertainty quantification, and federated learning capabilities provides both high accuracy and clinical interpretability, making it suitable for next-generation computer-aided diagnosis systems deployable on healthcare IoT edge devices.

Indexed as

Internet of ThingsLung NeoplasmsAlgorithmsFederated LearningHumansRadiomicsTomography, X-Ray Computed

Identifiers

PMID42430392
PMCPMC13354005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.